Ibrunat (Ibrutinib) 140mg Capsules – Precision Blood Cancer Treatment by Cordium Pharmaceuticals Pvt Ltd

Trusted Global Supplier of Ibrutinib 140mg for Leukemia & Lymphoma Management

Blood cancers are increasing worldwide, creating a growing demand for innovative targeted therapies. Ibrunat (Ibrutinib) 140mg Capsules, manufactured and supplied by Cordium Pharmaceuticals Pvt Ltd, is an advanced oral treatment used in the management of several B-cell malignancies.

Healthcare professionals and pharmaceutical importers across Kenya, Nigeria, Ghana, Philippines, Vietnam, United Arab Emirates, Saudi Arabia, Uzbekistan, Kazakhstan, United States, United Kingdom, and South Africa rely on affordable, quality-assured oncology medicines to support patient care.

What is Ibrunat (Ibrutinib) 140mg?

Ibrunat is an oral anti-cancer medication containing Ibrutinib 140mg, a targeted therapy that inhibits Bruton's Tyrosine Kinase (BTK), an important protein involved in the growth and survival of malignant B-cells.

Unlike traditional chemotherapy, Ibrutinib specifically targets cancer pathways while helping reduce damage to healthy cells.

Product Highlights

• Generic Name: Ibrutinib
• Brand Name: Ibrunat
• Strength: 140mg
• Dosage Form: Oral Capsules
• Therapeutic Class: BTK Inhibitor
• Category: Oncology Medicine

Conditions Treated with Ibrunat 140mg Capsules

Ibrunat is prescribed for the treatment and long-term management of:

Chronic Lymphocytic Leukemia (CLL)

A slow-growing blood cancer affecting lymphocytes.

Small Lymphocytic Lymphoma (SLL)

A closely related condition involving lymph nodes.

Mantle Cell Lymphoma (MCL)

An aggressive subtype of non-Hodgkin lymphoma.

Waldenström Macroglobulinemia (WM)

A rare lymphoma that affects blood plasma cells.

Marginal Zone Lymphoma (MZL)

A cancer originating in lymphoid tissue.

Chronic Graft-versus-Host Disease (cGVHD)

In selected patients following stem cell transplantation.

How Ibrutinib 140mg Works

Ibrutinib blocks BTK signaling inside abnormal B-cells.

By interrupting these pathways, the medicine helps:

• Slow cancer cell multiplication
• Reduce tumor burden
• Delay disease progression
• Improve long-term disease control
• Support personalized cancer treatment plans

Why Global Healthcare Providers Prefer Ibrunat

Key Advantages

✔ Targeted oral therapy

✔ Once-daily treatment convenience

✔ Supports long-term blood cancer management

✔ High-quality manufacturing standards

✔ Reliable international supply chain

✔ Suitable for global oncology programs

Safety Information

Patients should use Ibrunat strictly under specialist supervision.

Common Side Effects

• Fatigue
• Diarrhea
• Muscle pain
• Nausea
• Skin rash
• Bruising
• Low platelet count
• Increased risk of infections
• Elevated blood pressure

Patients should immediately report unusual bleeding, chest pain, or severe infections to their healthcare provider.

Precautions Before Starting Ibrutinib

Consult your physician if you have:

• Heart disease
• Liver disorders
• Bleeding conditions
• Recent surgery
• Active infections
• High blood pressure
• Pregnancy or breastfeeding concerns

Avoid taking herbal supplements or certain medications without medical advice.

Why Choose Cordium Pharmaceuticals Pvt Ltd?

Cordium Pharmaceuticals Pvt Ltd is committed to delivering affordable oncology solutions to international markets.

Our Global Capabilities

• WHO-GMP aligned manufacturing
• Oncology specialization
• International export expertise
• Bulk supply support
• Regulatory documentation assistance
• Timely delivery worldwide
• Quality-driven production processes

International Markets We Support

Africa

• Kenya
• Nigeria
• Ghana
• South Africa

Asia

• Philippines
• Vietnam
• Uzbekistan
• Kazakhstan

Middle East

• UAE
• Saudi Arabia

Europe & North America

• United Kingdom
• United States

Frequently Searched Questions

Is Ibrunat the same as Ibrutinib?

Ibrunat is a branded formulation containing Ibrutinib 140mg.

Is Ibrutinib chemotherapy?

No. It is a targeted therapy known as a BTK inhibitor.

Can Ibrutinib be taken at home?

Yes, it is an oral capsule, but treatment must be supervised by an oncologist.

Is a doctor's prescription required?

Yes. This medicine is prescription-only.